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Introduction. The idea of epigenetic reprogramming of cancer cells by an embryonic microenvironment 
possesses potential interest from the prospect of both basic science and potential therapeutic strategies. 
Chick embryo extract (CEE) has been used for the successful expansion of many specific stem cells 
and has demonstrated the ability to facilitate DNA demethylation. The current study was conducted to 
compare the status of DNA methylation in highly metastatic and less metastatic osteosarcoma cells and 
to investigate whether CEE may affect the epigenetic regulation of tumor suppressor genes and thus 
change the metastatic phenotypes of highly metastatic osteosarcoma cells. 
Materials and Methods. K7M2 murine OS cells were treated with CEE to determine its potential 
effect on DNA methylation, cell apoptosis, and invasion capacity. 
Results and Discussion. Our current results suggest that the methylation status of tumor suppressor 
genes (p16, p53, and E-cadherin) is significantly greater in highly metastatic mouse osteosarcoma K7M2 
cells in comparison with less metastatic mouse osteosarcoma K12 cells. CEE treatment of K7M2 cells 
caused demethylation of p16, p53, and E-cadherin genes, upregulated their expression, and resulted in 
the reversion of metastatic phenotypes in highly metastatic osteosarcoma cells. 
Conclusions. CEE may promote the reversion of metastatic phenotypes of osteosarcoma cells and can 
be a helpful tool to study osteosarcoma tumor reversion by epigenetic reprogramming. Demethylation 
of tumor suppressor genes in osteosarcoma may represent a novel strategy to diminish the metastatic 
potential of this neoplasm. Further studies, both in vitro and in vivo, are warranted to evaluate the clinical 
feasibility of this approach as an adjuvant to current therapy. 
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